Companies: 10,795·Total market cap: $144.5T
908 Devices Inc.

908 Devices Inc.

MASSNASDAQHealthcare● Active
$8.10
+$0.17(+2.14%)
Market Cap$306290330
P/E Ratio
52W High$9.34
52W Low$5.025

908 Devices Inc. (MASS) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

mass · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for 908 Devices Inc. (MASS) measures how much investors pay for each dollar of the company's trailing earnings. MASS's current PE ratio of N/A is calculated by dividing its stock price of $8.10 by its TTM earnings per share of -$0.97.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
FY2026 est. EPS $-0.29
Based on 2 analysts
EPS (TTM)
-$0.97
TTM · diluted EPS
PEG Ratio
0.00
Below 1.0 · Growth adjusted
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · 908 Devices Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

2018 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Devices · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
908 Devices Inc.
908 Devices Inc.You
MASS
$306MN/A-$0.97
Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc.
ACRS
$526MN/A-$0.53
Capricor Therapeutics, Inc.
Capricor Therapeutics, Inc.
CAPR
$1.2BN/A-$2.26
Cerus Corporation
Cerus Corporation
CERS
$521MN/A-$0.08
CVRx, Inc.
CVRx, Inc.
CVRX
$143MN/A-$2.04
Nano-X Imaging Ltd.
Nano-X Imaging Ltd.
NNOX
$127MN/A-$1.16
NeuroPace, Inc.
NeuroPace, Inc.
NPCE
$533MN/A-$0.66

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 8 of 8 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-1.01
2024-12-31
FY2024
$-2.12
2023-12-31
FY2023
$-1.13
2022-12-31
FY2022
$-1.07
2021-12-31
FY2021
$-0.79
2020-12-31
FY2020
$-2.34
2019-12-31
FY2019
$-1.78
2018-12-31
FY2018
$-0.93

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for 908 Devices Inc. (MASS) measures how much investors pay for each dollar of the company's trailing earnings. MASS's current PE ratio of N/A is calculated by dividing its stock price of $8.10 by its TTM earnings per share of -$0.97.

PE Ratio = Stock Price ÷ EPS (TTM)
= $8.10 ÷ -$0.97 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

MASS pe ratio · 6 questions

MASS's current PE ratio is N/A as of 2026-06-08, based on a stock price of $8.10 and TTM EPS of -$0.97. Data sourced from Financial Modeling Prep via MASS's SEC 10-K and 10-Q filings.

MASS PE ratioWhat is MASS PE ratioCurrent PE ratio of MASSMASS PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · 908 Devices Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08